Resistance on Antithrombotic Drugs in Ischemic Heart Disease
NCT00742430 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141
Last updated 2012-02-14
Summary
The purpose of this study is to determine whether aspirin and clopidogrel resistance measured with Multiplate function analyser has a good correlation with incidence of major adverse cardiac events in patients with coronary artery disease (CAD).
Conditions
Interventions
- PROCEDURE
-
PCI
percutaneous coronary intervention in stable coronary artery disease
Sponsors & Collaborators
-
University of Zagreb
lead OTHER
Principal Investigators
-
Davor Milicic, prof.dr.sc. · Clinic of Cardiovascular Diseases, Clinical Medical Centre Rebro, Zagreb, Croatia
-
Bosko Skoric, dr. · Clinic of Cardiovascular Diseases, Clinical Medical Centre Rebro, Zagreb, Croatia
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-02-28
- Completion
- 2011-08-31
Countries
- Croatia
Study Locations
More Related Trials
-
Aspirin and Clopidogrel Resistance Study
NCT01039480 ·Status: COMPLETED
-
Platelet Function in Patients With an Acute Coronary Syndrome
NCT01992484 ·Status: UNKNOWN
-
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
NCT01586975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Monitoring Response to Antiplatelet Therapy
NCT00327041 ·Status: UNKNOWN
-
Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator
NCT02331511 ·Status: UNKNOWN ·Phase: NA
-
Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI
NCT04981041 ·Status: UNKNOWN ·Phase: PHASE4
-
Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
NCT00735280 ·Status: COMPLETED ·Phase: PHASE4
-
ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures
NCT00593762 ·Status: SUSPENDED
-
Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy
NCT01852162 ·Status: COMPLETED ·Phase: NA
-
Platelet Drug Trial in Coronary Disease Progression
NCT00000496 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs
NCT04401761 ·Status: COMPLETED
-
Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions
NCT05732701 ·Status: RECRUITING ·Phase: NA
-
Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
NCT01103440 ·Status: COMPLETED ·Phase: PHASE2
-
AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).
NCT03317002 ·Status: COMPLETED ·Phase: PHASE2
-
Perioperative Aspirin Response in Patients Undergoing Vascular Surgery
NCT03587324 ·Status: COMPLETED ·Phase: NA
-
Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation
NCT00822536 ·Status: COMPLETED ·Phase: PHASE4
-
Antiplatelet Drug Resistances and Ischemic Events
NCT00501423 ·Status: COMPLETED
-
Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen
NCT03023020 ·Status: COMPLETED ·Phase: NA
-
The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man
NCT02120092 ·Status: COMPLETED ·Phase: PHASE2
-
Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) Surgery
NCT01174862 ·Status: COMPLETED
-
Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome
NCT06254391 ·Status: RECRUITING ·Phase: PHASE2
-
Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI
NCT01642134 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Reactivity and MES During CEA
NCT01547039 ·Status: UNKNOWN
-
Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
NCT01023360 ·Status: UNKNOWN ·Phase: PHASE4
-
Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers
NCT02618837 ·Status: UNKNOWN ·Phase: PHASE4